Navigation Links
Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
Date:5/16/2012

dy of scientific knowledge in this area."

Additional Presentations of Boehringer Ingelheim Investigational CompoundsIn addition to the LUX-Lung 3 presentation, more than 15 studies of Boehringer Ingelheim's investigational therapies have been selected for inclusion at ASCO, demonstrating the company's innovative clinical development program across a variety of cancer types.Select Poster PresentationsTitleLead AuthorPoster detailsAfatinibLUX-breast 3: Randomized phase II study of
afatinib alone or with vinorelbine versus
investigator's choice of treatment in patients (pts)
with HER2-positive breast cancer (BC) with
progressive brain metastases (BM) after
trastuzumab or lapatinib-based therapy.

Heikki Joensuu, MD, Professor

 

 

 

Abstract #TPS647

Poster #15B

Date: Saturday, June 2
Time: 8:00 AM - 12:00 PM CDT

 

 LUX-breast 1: Randomized, phase III trial of
afatinib and vinorelbine versus trastuzumab and
vinorelbine in patients with HER2-overexpressing
metastatic breast cancer (MBC) failing one prior
trastuzumab treatment.

Nadia Harbeck, MD, PhD

 

 

 

Abstract #TPS649

Poster #15D

Date: Saturday, June 2
Time: 8:00 AM - 12:00 PM CDT

 LUX-breast 2: Phase II, open-label study of oral
afatinib in HER2-overexpressing metastatic breast
cancer (MBC) patients (pts) who progressed on
prior trastuzumab (T) and/or lapatanib (L).

Tamas Hickish, MD

 

 

 

Abstract # TPS651

Poster #15F

Date: Saturday, June 2
Time: 8:00 AM - 12:00 PM CDTLUX-head and neck 1: A phase III, randomized
trial of afatinib versus methotrexate (MTX) in
patients (pts) with recurrent/metastatic (R/M)
head and neck squamous cell carcinoma (HNSCC)
who progressed after platinum-based
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), ... repair and regeneration, today announced that J.J. Finkelstein ... present a corporate overview at two upcoming investor conferences. ... SeeThruEquity 4 th Annual Microcap Conference on Thursday ... at 11:00 am EDT.  A webcast will ...
(Date:5/22/2015)... OF PRUSSIA, Pa. , May 22, 2015  The ... Behring its 2015 Corporate Leadership Award as recognition for ... improving the care of the bleeding disorders community.  The award ... Director, CSL Limited, during the NHF Annual Spring Soiree in ... "The National Hemophilia Foundation is dedicated to finding ...
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma ... diagnosed victims of mesothelioma get the best possible ... certain individuals with this rare cancer caused by ... most up-to-date information related to treatment options such ... please call the Mesothelioma Victims Center anytime at ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... 26, 2012  A minimally invasive treatment may target hunger ... to block arteries to the stomach and suppress hunger ... to repair vertebral disc degeneration. Initial results from all ... Radiology,s 37th Annual Scientific Meeting in San Francisco, Calif. ...
... Quest International, Inc., a leading global supplier of ... today that is has contributed $5000 to the American ... Cancer Society Key Gala, that benefits the Boston Hope ... Thursday, March 29, 2012. "We are pleased ...
Cached Medicine Technology:No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 2No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 3No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 4No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 5No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 6Quest International Donates $5000 to the American Cancer Society 2
(Date:5/23/2015)... D.C. (PRWEB) May 23, 2015 On ... of powers of a youngster's yogic power learned through ... Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, a ... more than 50 high profile professionals attending the 2015 ... by reading fluently -- blindfolded. , In a ...
(Date:5/23/2015)... 23, 2015 On May 16, the team ... event was a 5k mud obstacle run that raised funds ... million people worldwide, and the reason we participated was to ... Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the ... , The event was not only attended by eXtreme Bodyshaping ...
(Date:5/23/2015)... May 23, 2015 Add High-Quality prismatic refractions ... Film Studios. , It's as simple as dragging and dropping ... included tool for full effect. , Including over 80 ... range 5k sensors making this the ultimate bundle for adding ... included in this package are movie files designed for Final ...
(Date:5/22/2015)... The American College of Traditional Chinese Medicine ... will hold a webinar on the updates of the ... Classical Chinese Medicine. , Webinar – First Professional Doctorate ... Dean of Clinical Education, will lead this webinar in ... program. ACTCM is currently developing this degree program based ...
(Date:5/22/2015)... 22, 2015 Following yesterday’s announcement that ... with US-based health brand Nature’s Way, Marc St-Onge has ... of Ascenta Skin is an integral part of the ... this opportunity to further develop Ascenta Skin into a ... Skin is a breakthrough, anti-aging skincare supplement featuring 6 ...
Breaking Medicine News(10 mins):Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:ACTCM Announces Upcoming June Events 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... will spread and so need aggressive treatment. Researchers at University ... a computer is taught to spot patterns //- in combination ... natural language. The result is a model which can scrutinize ... is the tumor will spread. ,Tested on samples ...
... 3 million Americans age 12 to 18 considered suicide in ... kill themselves, a government survey found. According to the on ... boys// to have thought about or tried to commit suicide. ... Mental Health Services Administration, showed that only one in three ...
... women who suffer from premenstrual syndrome, or PMS. A ... women who have exhausted all other medications without help.// ... Center in Philadelphia, set out to determine whether half-cycle ... is started 14 days prior to the start of ...
... liver oil followed by a chewy, multi-vitamin tablet with ... New studies show children with otitis media, or middle ... infections once they began taking vitamin/mineral supplements and cod ... omega-3 fatty acids. ,Otitis media is common and ...
... women with high levels of lead in their bones face ... lead from sources like old pain, researchers reported recently. In ... of lead exposure// “may constitute a significant public health problem, ... bone.” ,The findings demonstrated that protecting children from the ...
... being paid to enrol them in a clinical trial. Post-marketing ... part of medical research. It involves giving patients a new ... arise. The post-marketing phase will involve many more patients than ... be an important way of revealing uncommon side effects. ...
Cached Medicine News:
... new Platinum 10 concentrator. The Platinum 10 ... you have come to expect from the ... attractive alternative to liquid systems. The Platinum ... LPM for high flow patients, and has ...
... ,AirSeps AirLife On-board Oxygen Concentrators were ... supplemental oxygen passengers and are still in ... the US governments FAA/STC approval for this ... commercial aircraft, AirSep set the standard years ...
... November 2005. Specifications, including colors, subject to ... lb (2.3 kg), FreeStyle by AirSep is ... for those patients who know no boundaries. ... FreeStyle captures the heart of what it ...
... Oxygen Concentrator is the most compact, lightweight ... lbs (4.5 kg), this unit was designed ... active oxygen patient., ,Operating as a ... of both an oxygen concentrator and an ...
Medicine Products: